✦ LIBER ✦

HIV-1 infected patients older than 50 years. PISCIS cohort study

✍ Scribed by G. Navarro; M.M. Nogueras; F. Segura; J. Casabona; J.M. Miro; J. Murillas; C. Tural; E. Ferrer; A. Jaén; L. Force; J. Vilaró; I. García; A. Masabeu; J. Altés; A. Esteve; O. Sued; M. Riera; B. Clotet; D. Podzamczer; J.M. Gatell

Book ID: 108174574
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 244 KB
Volume: 57
Category: Article
ISSN: 0163-4453
DOI: 10.1016/j.jinf.2008.05.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High Prevalence of Colorectal Adenomas A

High Prevalence of Colorectal Adenomas Among Asymptomatic HIV-Infected Patients 50 Years of Age and Older: A Prospective Screening Colonoscopy Study

✍ Edmund J. Bini; Bryan Green; Michael A. Poles 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 57 KB

71 Discontinuation of enfuvirtide after

71 Discontinuation of enfuvirtide after long-term administration in HIV-1-infected patients: the Swiss HIV cohort study (SHCS)

✍ L. Elzi; G. Kaufmann; R. Weber; B. Hirschel; M. Cavassini; H. Furrer; E. Bernasc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Early versus deferred antiretroviral the

Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial

✍ Thanyawee Puthanakit; Vonthanak Saphonn; Jintanat Ananworanich; Pope Kosalaraksa 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 259 KB

Timing of initiation of antiretroviral t

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 250 KB

Predictive factors of treatment interrup

Predictive factors of treatment interruption duration in a cohort of HIV-1 infected patients with CD4 count greater than 350 cells per mm3

✍ J. Fillaux; C. Delpierre; M. Alvarez; A. Jaafar; B. Marchou; P. Massip; L. Cuzin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 French ⚖ 331 KB

Switching to emtricitabine, tenofovir an

Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study

✍ Gantner, P; Reinhart, S; Partisani, M; Baldeyrou, M; Batard, M-L; Bernard-Henry, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB